🇺🇸 FDA
Patent

US 11498969

Compositions and methods for treating juvenile idiopathic arthritis

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 11498969 (Compositions and methods for treating juvenile idiopathic arthritis) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K2039/545, A61P, A61P19/02